Amgen (AMGN) Stock Price, Fundamentals & Analysis

What AMGN does

Amgen (AMGN) discovers, develops, manufactures, and delivers human therapeutics worldwide. Its portfolio includes treatments for rheumatoid arthritis, plaque psoriasis, osteoporosis, multiple myeloma, and other conditions, with products such as Enbrel, Otezla, Prolia, XGEVA, Repatha, KYPROLIS, and BLINCYTO. The company operates in the Healthcare sector, specifically in the Drug Manufacturers – General industry, and is headquartered in Thousand Oaks, United States. Amgen is part of the S&P 500.

Key numbers explained

• 406.09 USD is the current share price, representing what one share costs in the market right now.
• The trailing P/E ratio of 25.3 compares the share price to the last 12 months of earnings; a higher number can suggest the market expects strong future growth.
• The forward P/E ratio of 16.6 uses expected future earnings, which can make the stock look cheaper if those expectations hold.
• 2.46% is the dividend yield, showing the annual dividend as a percentage of the share price.
• The ex-dividend date of Aug 21, 2026 is the cutoff to own the stock and receive the next dividend payment.
• 61% of earnings are paid out as dividends, indicating how much of the company's profit is returned to shareholders.
• 0.43 is the beta, a measure of volatility relative to the market; a value below 1 suggests the stock tends to move less than the overall market.
• The 52-week range of 269.77 – 447.03 shows the lowest and highest prices over the past year.

Recent news

Amgen's price target was raised by Jefferies to $410 from $367, with a Hold rating, following positive data in a Sjögren's disease study. The company also announced that its drug Dazodalibep met its goal in a systemic Sjögren's disease trial, which contributed to recent gains in the stock price.

What to watch

For a stock like Amgen, investors typically monitor pipeline progress and clinical trial results, as new data can shift sentiment. Regulatory decisions, patent expirations, and competition within the Drug Manufacturers – General industry also matter. Broader factors such as interest rates, healthcare policy changes, and movements in the S&P 500 can affect the stock's price. Comparing Amgen with peers like Vertex Pharmaceuticals (VRTX) or McKesson Corporation (MCK) can provide context on sector trends.